Tri-State (NY/NJ/CT) CACS Annual Symposium Held in New Jersey
Tri-State (NY/NJ/CT) CACS held its annual symposium on June 25, 2005,
at Shering-Plough Research Institute, Kenilworth, New Jersey. The theme of
this symposium is “Chemical and Pharmaceutical R&D in a Global Environment.”
ACS president Bill Carroll attended the symposium and gave the opening
presentation. He gave a prospective of the American chemical enterprise in
15 years, laying out the trend of globalization and its effect on American
chemical industry, government policies, and research at academic institutions
as well as government labs. His message was that change is inevitable, and the
American chemical enterprise is better off prepared to face the challenges.
He also spoke of his recent visit, as a part of an ACS delegation, to China,
pointing out some of the common issues he had noticed that face the two
countries (drawing students’ interest to science, for example).
Other speakers at the symposium were either top managers at industrial
research labs or successful chemical entrepreneurs of Chinese origin.
Dr. Rene Imwinkelried, the vice president of Process Chemistry at Shering-Plough,
gave a talk on “How China Will Become a Valuable Outsourcing Partner for
Drug Development,” in which he remarked that the trend toward globalized
effort in the process of drug development is inevitable. Outsourcing is
an effective way of improving a company’s competitiveness. Pharmaceutical
companies should seize the opportunity and benefit from it.
In a joint presentation, Dr. Ge Li, CEO of WuXi Pharmatechs, and
Dr. Richard Soll, CSO of Targegen, shared their international collaborative
experience with the audience. Mr. Paul Guo, CEO of AstaTech, spoke on his
experience in managing human resources in an international company.
Dr. Wuping Ma, president of SynChem, told the audience his thought process
in starting up and growing his company, which changed from a venture for
personal success to company success for all its employees. His company currently
employs 70 people, 20 in Chicago and 50 in Shanghai.
A rarity at this symposium was a professor entrepreneur, Prof. Xumu Zhang
of Penn State University. His world-class research in chiral catalysis led
to the founding of ChiralQuest in 2000, which is listed in NASDAQ. Prof. Zhang
described the product line of ChiralQuest and outlined its business plan which
included expanding operations to China. His story was an inspiration to the
symposium attendees.
“This year’s symposium had the strongest program in all the years of Tri-State CACS
symposium,” remarked Dr. Yuguang Wang, the president of Tri-State CACS. Twelve
speakers offered an audience of 150 a full day of informative perspective on
R&D in a changing environment. “Our motto for the symposium is,” according to
Dr. Wang, “that the theme must be the most interesting, the speakers must be
top-notch in chemical and pharmaceutical areas, and the audience must benefit
from it.” As in the past, the symposium required no registration fees, and free
breakfast and lunch were provided.
Chemistry, Chemistry of Drug Discovery and Development,
Chemistry Outsourcing and Entrepreneurial Opportunity
Date: June 25, 2005
Place: Schering-Plough Research Institute
2015 Galloping Hill Rd, Kenilworth, NJ 07033
Program
- 8:15 am-8:45 am Registration and Continental Breakfast
- 8:45 am-8:50 am Opening Remark
- 8:50 am -9:30 am Bill Carroll, President of American Chemical Society
(Title: Some Thoughts on the Enterprise, ACS and its
Membership: The Next Ten Years)
- 9:30am -10:10 am John Elingboe, Senior Director of Chemistry, Wyeth
(Title: The Identification of Leads for Drug Discovery)
- 10:10am- 10:40 am Neng-Yang Shi, Senior Director of Chemical Research, Schering Plough
(Title: From Marijuana To Modern Medicines: Recent
Advances in Cannabinoid Receptor Ligands)
- 10:40 am- 11:20 am William Murray, VP of Discovery Research, Johnson & Johnson
(Title: An Electrocyclic Strategy to Generate Densely
Functionalized Templates for Library Synthesis)
- 11:20 am- 12: 00 pm Rene Imwinkelried, VP of Process Chemistry, Schering-Plough
(Title: How China will become a valuable outsourcing partner
for drug development)
- 12:00 pm -1:30 pm Lunch
- 1:30 pm-2:00 pm Hongxiang Lou, Dean of School of Pharmacy, Shandong University, China
(Title: Development of Natural Product to Medicine)
- 2:00 pm- 2:30 pm Yongkiu Sun, Director of the Catalysis and Reaction Discovery and Development Lab, Merck
(Title: Unlock the Potential of Asymmetric Hydrogenation at Merck)
- 2:30 pm-2:50 pm Paul Guo, President of AstaTech
(Title: Challenge in Muti-Site Human Resources Management For a Chemistry Outsourcing Company)
- 2:50 pm-3:10 pm Ping Cao, Marketing Manager of Tyger Scientific
(Title: Reliable, Confidential, and Timely---Tyger Scientific)
- 3:10 pm- 3:30 pm Xumu Zhang, Chief Scientific Officer, Chiral Quest
(Title: Development of Commercial Scale Chiral Catalysts,
Efficient Processes for Making Drugs)
- 3:30 pm-3:50 pm Wuping Ma, President of SynChem
(Title: Ups and Downs with SynChem, Inc.
----Surviving in Outsourcing Chemistry Jungle)
- 3:50 pm-4:00 pm Closing Remark
Registration: Registration is free. Please register on line at http://www.tristatecacs.org
Contact: Guang Cao: 908-730-2103; Xiaoqiu Wu: 732-000-0000
Yuguang Wang; 908-740-3508
Tristate CACS Annual Meeting 2005
Date & Time: 8:45 am to 4:10 pm; June 25, 2005
Place: Schering-Plough Research Institute
Address:
2015 Galloping Hill Rd
Kenilworth, NJ 07033
Meeting Focuses: Chemistry, Chemistry of Drug Discovery and Development, Chemistry Outsourcing and Entrepreneurial Opportunity
Speakers:
- Bill Carroll, President of ACS
- John Elingboe, Senior Director of Chemistry, Wyeth
- Neng-Yang Shi, Senior Director of Chemical Research, Schering-Plough
- William Murray, Vice President of Discovery, Johnson & Johnson
- Rene Imwinkelreid, Vice President of Process Chemistry, Schering-Plough
- Hongxiang Lou, Dean of School of Pharmacy, Shandong University, China
- Yongkiu Sun, Director of Chemistry, Merck
- Paul Mar, President of SynChem
- Ping Cao, Marketing Manager of Tyger Scientific
- Xumu Zhang, Chief Scientific Officer, Chiral Quest
- Paul Guo, President of AstaTech
Registration: Free
|
Contact Us
